| Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) P Knoebl, P Marco, F Baudo, P Collins, A Huth‐Kühne, L Nemes, ... Journal of Thrombosis and Haemostasis 10 (4), 622-631, 2012 | 688 | 2012 |
| Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B W Miesbach, K Meijer, M Coppens, P Kampmann, R Klamroth, ... Blood, The Journal of the American Society of Hematology 131 (9), 1022-1031, 2018 | 379 | 2018 |
| Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis GJ Geersing, NPA Zuithoff, C Kearon, DR Anderson, AJ Ten Cate-Hoek, ... Bmj 348, 2014 | 308 | 2014 |
| Clinical severity of haemophilia A: does the classification of the 1950s still stand? IEM Den Uijl, EP Mauser Bunschoten, G Roosendaal, REG Schutgens, ... Haemophilia 17 (6), 849-853, 2011 | 299 | 2011 |
| Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis REG Schutgens, P Ackermark, F Haas, HK Nieuwenhuis, HG Peltenburg, ... Circulation 107 (4), 593-597, 2003 | 258 | 2003 |
| COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year J Leentjens, TF Van Haaps, PF Wessels, REG Schutgens, S Middeldorp The Lancet Haematology 8 (7), e524-e533, 2021 | 256 | 2021 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 235 | 2021 |
| How I treat age-related morbidities in elderly persons with hemophilia PM Mannucci, REG Schutgens, E Santagostino, EP Mauser-Bunschoten Blood, The Journal of the American Society of Hematology 114 (26), 5256-5263, 2009 | 228 | 2009 |
| Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled … M Teraa, RW Sprengers, REG Schutgens, ICM Slaper-Cortenbach, ... Circulation 131 (10), 851-860, 2015 | 221 | 2015 |
| Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level MJ Agterof, REG Schutgens, RJ Snijder, G Epping, HG Peltenburg, ... Journal of Thrombosis and Haemostasis 8 (6), 1235-1241, 2010 | 206 | 2010 |
| Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded RA Douma, M Tan, REG Schutgens, SM Bates, A Perrier, C Legnani, ... haematologica 97 (10), 1507, 2012 | 184 | 2012 |
| Pathophysiology of hemophilic arthropathy and potential targets for therapy AE Pulles, SC Mastbergen, REG Schutgens, FPJG Lafeber, ... Pharmacological research 115, 192-199, 2017 | 175 | 2017 |
| Cardiovascular disease in patients with hemophilia A Tuinenburg, EP Mauser‐Bunschoten, MC Verhaar, DH Biesma, ... Journal of Thrombosis and Haemostasis 7 (2), 247-254, 2009 | 160 | 2009 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 152 | 2023 |
| Co‐morbidity in the ageing haemophilia patient: the down side of increased life expectancy EP Mauser‐Bunschoten, DE Fransen Van De Putte, REG Schutgens Haemophilia 15 (4), 853-863, 2009 | 150 | 2009 |
| Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions KPM van Galen, ET Engelen, EP Mauser‐Bunschoten, RJJ van Es, ... Cochrane Database of Systematic Reviews, 2019 | 146 | 2019 |
| Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study NS GIBSON, SM SCHELLONG, DY El KHEIR, J Beyer‐Westendorf, ... Journal of Thrombosis and Haemostasis 7 (12), 2035-2041, 2009 | 145 | 2009 |
| Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... Jama 329 (13), 1066-1077, 2023 | 104 | 2023 |
| Review of immune tolerance induction in hemophilia A SJ Schep, REG Schutgens, K Fischer, ML Boes Blood Reviews 32 (4), 326-338, 2018 | 102 | 2018 |
| Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline REG Schutgens, A Tuinenburg, G Roosendaal, SH Guyomi, ... Haemophilia 15 (4), 952-958, 2009 | 102 | 2009 |
